RxDoctor Payments Data

Joshua Vova

Pediatric Rehabilitation Medicine · Atlanta, GANPI 1760451322

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $99,569 of the $146,561 with a category attached, or 67.9%. Ipsen Biopharmaceuticals, Inc accounts for 91.7% of it on its own, with 8 other manufacturers making up the rest.

$146,561in general payments, 2019–2025

Across 152 payments — averaging $964.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ipsen Biopharmaceuticals, Inc$134K
  • Merz Pharmaceuticals, LLC$6K
  • Pacira Pharmaceuticals Incorporated$3K
  • Medtronic$2K
  • Janssen Global Services, LLC$1K
  • AbbVie$62
  • plus $63 from 3 others
$2,366in research payments, 2019–2025

Across 4 payments — averaging $591.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$2K

What the payments were for

  • Consulting fees$22,74016%
  • Speaking & faculty fees$99,56968%
  • Travel & lodging$18,92113%
  • Food & beverage$5,3304%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric rehabilitation medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.

Other pediatric rehabilitation medicine in Atlanta

Where these figures come from

Is this you, or does something look wrong? →